0      0

2022 ISPE Europe Annual Conference

EU22CEAPR1/SES208 - GeneNCure, a Fictional Company Created for a 6-months Student Project - From Development to Production of a Nebulized Treatment Against Cystic Fibrosis Using mRNA Technology


Apr 27, 2022 3:20pm ‐ Apr 27, 2022 4:00pm


Description

This case study is a tutored project whose objective is to create a fictitious pharmaceutical laboratory and market a product, also fictitious. During this year 2021/2022, our group of 60 students has decided to focus on the strong potential of mRNA as a treatment for cystic fibrosis. We attend to this conference to present 2 aspects : how we developed our medication, Muscidarn, and the way to produce it.

Speaker(s):

You must be logged in and own this session in order to post comments.